ProfessorRolandVeltkamp

Faculty of Medicine, Department of Brain Sciences

Professor of Neurology and Chair of Stroke Medicine

Contact

Location

3 East6East WingCharing Cross Campus

Summary

Roland Veltkamp received his clinical training as a stroke neurologist in Heidelberg, Germany, and at Wake Forest University School of Medicine, USA. His research interests encompass emergency therapy of ischemic and hemorrhagic stroke and stroke prevention in atrial fibrillation. His research has led to new methods of Afib detection on the stroke unit and to the improvement of acute stroke management in patients on anticoagulants. His translational stroke research group investigates the role of the immune system after stroke. In a landmark study, his group has described a major protective role of regulatory T cells in experimental stroke. Recent findings in his laboratory have led to a phase II clinical stroke trial testing the effect of the leukocyte adhesion blocker natalizumab in stroke.

Currently, Prof. Veltkamp serves as a member of the Board of Directors of the European Stroke Organisation and is an international delegate of the program committee of the AHA International Stroke Conference.

Publications

Journals

Prats-Sanchez L, Camps-Renom P, Nash PS, et al.Prats-Sanchez L, Camps-Renom P, Nash PS, Wilson D, Ambler G, Best JG, Guasch-Jiménez M, Ramos-Pachón A, Martinez-Domeño A, Lambea-Gil Á, Díaz GE, Guisado-Alonso D, Du H, Al-Shahi Salman R, Jäger HR, Lip GY, Ay H, Jung S, Bornstein NM, Gattringer T, Eppinger S, van Dam-Nolen DH, Koga M, Toyoda K, Fluri F, Phan TG, Srikanth VK, Heo JH, Bae H-J, Kelly PJ, Imaizumi T, Staals J, Köhler S, Yakushiji Y, Orken DN, Smith EE, Wardlaw JM, Chappell FM, Makin SD, Mas J-L, Calvet D, Bordet R, Chen CP, Veltkamp R, Kandiah N, Simister RJ, De Leeuw F-E, Engelter ST, Peters N, Soo YO, Zietz A, Hendrikse J, Mess WH, Werring DJ, Marti-Fabregas J, Microbleeds International Collaborative Network (MICON) close, 2024, Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds., Neurology, Vol:102

Strunk D, Bauer P, Keyvani K, et al.Strunk D, Bauer P, Keyvani K, Diehl RR, Veltkamp R, Berlit P, Meuth SG, Timmermann L, Schwitalla JC, Kraemer M close, 2024, Moyamoya disease in Southeast Asians: genetic and autopsy data, new cases, systematic review, and meta-analysis of all patients from the literature., J Neurol

Wafa HA, Marshall I, Wolfe CDA, et al.Wafa HA, Marshall I, Wolfe CDA, Xie W, Johnson CO, Veltkamp R, Wang Y, PRESTIGE-AF consortium close, 2024, Burden of intracerebral haemorrhage in Europe: forecasting incidence and mortality between 2019 and 2050., Lancet Reg Health Eur, Vol:38

Al-Shahi Salman R, Stephen J, Tierney JF, et al.Al-Shahi Salman R, Stephen J, Tierney JF, Lewis SC, Newby DE, Parry-Jones AR, White PM, Connolly SJ, Benavente OR, Dowlatshahi D, Cordonnier C, Viscoli CM, Sheth KN, Kamel H, Veltkamp R, Larsen KT, Hofmeijer J, Kerkhoff H, Schreuder FHBM, Shoamanesh A, Klijn CJM, van der Worp HB, Collaboration of Controlled Randomised Trials of Long-Term Oral Antithrombotic Agents After Spontaneous Intracranial Haemorrhage (COCROACH) close, 2023, Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials., Lancet Neurol, Vol:22, Pages:1140-1149

Ingwersen T, Olma MC, Schlemm E, et al.Ingwersen T, Olma MC, Schlemm E, Mayer C, Cheng B, Tuetuencue S, Kirchhof P, Veltkamp R, Roether J, Laufs U, Nabavi DG, Ntaios G, Endres M, Haeusler KG, Thomalla G close, 2023, Independent external validation of a stroke recurrence score in patients with embolic stroke of undetermined source, Neurological Research and Practice, Vol:5

More Publications